• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Oncology Digital Health Startups

Oncology Analytics Lands $28M to Expand Oncology Capabilities

by Fred Pennic 05/26/2020 Leave a Comment

Oncology Analytics Lands $28M to Expand Oncology Capabilities

What You Should Know: - Oncology Analytics raises $28M in Series C funding led by Baird Capital to expand its oncology-focused capabilities, accelerate real-world data and analytics solutions for health plans, and increase the market share of its technology-enabled utilization management solution.  - Oncology Analytics' prior authorization platform is used by physicians to support 5 million health plan members in the US and Puerto Rico and covers the full spectrum of therapeutics, across
Read More

Biofourmis Acquires Digital Therapeutics Oncology Startup Gaido Health

by Fred Pennic 04/16/2020 Leave a Comment

Biofourmis Expands into Oncology Market with Strategic Acquisition of Gaido Health

What You Should Know: - Boston-based digital therapeutics startup Biofourmis acquires LA-based Gaido Health from Takeda Pharmaceuticals, in a strategic deal that expands Biofourmis’ portfolio in the oncology space. - Gaido Health—a digital therapeutics company focused on the oncology market—was part of Takeda Digital Ventures, Takeda’s corporate technology investment and incubation arm. - With Gaido Health’s and Biofourmis’ dual focus on remote monitoring with wearables
Read More

Navigating Cancer Lands $26M to Expand Oncology Patient Relationship Management Platform

by Fred Pennic 09/17/2019 Leave a Comment

Navigating Cancer Lands $26M to Expand Oncology Patient Relationship Management Platform

- Navigating Cancer raises $26M in Series D funding in an over-subscribed round (TTCP) for its comprehensive oncology patient relationship management solution. - Navigating Cancer’s PRM platform helps providers manage patient interactions, improve the patient experience, and deliver value-based care more effectively – increasing the flow of communications between in-office visits, which, in turn, boosts patient engagement in their own care. - Funding will enable NC to accelerate innovation of
Read More

Proteus Launches Digital Cancer Chemotherapy Pill Program for Cancer Patients

by Jasmine Pennic 01/18/2019 Leave a Comment

Proteus Digital Health

Proteus Digital Health, Inc., Fairview Health Services, and the University of Minnesota Health announced that for the first time cancer patients are using digital oncology medicines to support treatment regimens and improve outcomes. This advancement helps patients complete oral chemotherapy cycles while oncologists gain new insights into their patients’ treatment progress and overall health status. Proteus, Fairview, and the University of Minnesota Health unveiled the care model for digital
Read More

Dutch Startup Launches First Cancer Fatigue App to Support Cancer Patients & Survivors

by Fred Pennic 12/06/2018 Leave a Comment

Dutch Startup Launches First Cancer Fatigue App to Support Cancer Patients & Survivors

Tired of Cancer, a Dutch-based digital health startup whose mission to help as many cancer patients and survivors fight cancer-related fatigue (CRF), today announced the first mobile app to address CRF. Now available for free, the Untire app is the first digital solution to support the 30-40% cancer patients and survivors suffering from cancer fatigue worldwide.Fatigue: The Most Common Side Effect of CancerCRF, characterized by feelings of exhaustion and weakness is the most common side effect
Read More

Proscia Raises $8M for AI-Enhanced Digital Pathology for Cancer Diagnosis

by Jasmine Pennic 09/26/2018 Leave a Comment

Proscia Raises $8M for AI-Enhanced Digital Pathology for Cancer Diagnosis

Proscia, a Philadelphia-based digital pathology platform has raised $8.3 million in Series A funding led by Boston-based Flybridge Capital Partners with participation from Emerald Development Managers, Fusion Fund, Razor’s Edge Ventures, and RobinHood Ventures.The startup plans to utilize the Series A funding to fuel the development and commercialization of new, clinical AI-enabled workflows targeting high-volume, high-impact cancers, the first of which will be available later this year. In
Read More

Cernostics Raises $2.5M for Next Generation Cancer Diagnostics

by Fred Pennic 03/22/2018 Leave a Comment

Cernostics Raises $2.5M for Next Generation Cancer Diagnostics

Cernostics, a Pittsburgh, PA-based diagnostics company focused on delivering better cancer diagnosis and prognosis through a unique approach to tissue analysis has raised $2.5 million in Series A funding led by Illumina Ventures. With the recent investment from Illumina Ventures, Cernostics has raised a total of $13 million, including investments from UPMC Enterprises, Novitas Capital, Geisinger Health System, the Pittsburgh Life Sciences Greenhouse, and Ben Franklin Technology Partners of
Read More

Precision Health AI Launches Oncology AI Platform Driven by EMR Dataset

by HITC Staff 03/01/2018 Leave a Comment

Precision Health AI Launches Oncology AI Platform Driven by EMR Dataset

Precision Health AI, a healthcare technology company focused on the application of artificial intelligence to cancer care, today announced the launch of the Eureka Health Oncology AI Platform. The 60+ set of pre-trained AI solution modules will utilize Precision Health AI’s proprietary data to predict a patient’s cancer stage, treatment journey, flow through the healthcare system and survival rate.Driving the new Eureka Health Oncology AI platform is Precision Health AI’s deep, longitudinal
Read More

NantCare Unveils Solutions to Support CMS Oncology Care Model

by HITC Staff 11/03/2016 Leave a Comment

NantCare Unveils Solutions to Support CMS Oncology Care Model

NantCare, a member of the NantWorks will be providing community oncology practices with solutions  and resources that will help these practices comply with the administrative and clinical requirements put forth by the CMS’ new Oncology Care Model (OCM). Typically only available at large cancer institutions,  NantCare will provide access to clinical trials through facilitation of participation in Cancer MoonShot 2020’s QUILT Trials, eliminating the need for patients to travel to major cancer
Read More

FDA, Flatiron Health Team Up for Cancer Research Initiative

by HITC Staff 05/26/2016 Leave a Comment

Is Artificial Intelligence the Key to Curing Cancer

Flatiron Health and the FDA have teamed up on a new research collaboration agreement to determine how real-world evidence derived from de-identified, HIPAA-compliant patient data captured outside of clinical trials can provide new insights into the safety and effectiveness of emerging anti-cancer therapies such as immunotherapeutic agents.Research Initiative DetailsAs part of this research initiative, Flatiron Health and the FDA are collaborating on a project to investigate the use of
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |